Literature DB >> 3421425

Surgical treatment of Graves' disease.

J P Ozoux1, L de Calan, G Portier, B Rivallain, J P Favre, A Robier, D Goga, J Brizon.   

Abstract

Seven men and 81 women were operated on for Graves' disease. Their median age was 33 years. Eleven patients underwent a bilateral subtotal lobectomy; 77 patients underwent a complete lobectomy with contralateral partial lobectomy. Forty-seven patients were treated before 1981. In these patients, the weight of the thyroid remnant was estimated empirically between 5 and 12 g. In the 41 patients treated since 1981, the remnant weight was estimated at 5 g by comparative weighing. There were no postoperative deaths. Functional results were established in 83 patients with an average follow-up of 50 months (range 12 to 156 months), with control of vocal cord mobility demonstrated by indirect laryngoscopy in 66 patients. Hormonal determinations were carried out in 74 patients. There were no cases of permanent hypoparathyroidism. Three patients (4.5 percent) had unilateral vocal cord dysfunction. Twelve patients (14.5 percent) had clinical and biologic hypothyroidism, which occurred within 1 year postoperatively in 11 cases. Seven patients (8.3 percent) had latent hypothyroidism only discovered by hormonal determinations. Fifteen patients (17.8 percent) had recurrent hyperthyroidism, 6 of whom were diagnosed by hormonal determinations. The actuarial recurrence rate increased progressively up to the sixth postoperative year. The only predictive factor for recurrence was the type of operation. Patients who underwent a bilateral subtotal lobectomy had more recurrences than patients who underwent a complete lobectomy with partial contralateral lobectomy (p less than 0.01). These results suggest that patients should be followed closely for many years and should undergo hormonal determinations regularly, as some recurrences can occur 5 years or more after operation with very few symptoms.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3421425     DOI: 10.1016/s0002-9610(88)80060-6

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  7 in total

Review 1.  Endemic goiter and endemic thyroid disorders.

Authors:  E Gaitan; N C Nelson; G V Poole
Journal:  World J Surg       Date:  1991 Mar-Apr       Impact factor: 3.352

2.  Subtotal thyroidectomy: a reliable method to achieve euthyroidism in Graves' disease. Prognostic factors.

Authors:  Pablo Moreno; José M Gómez; Núria Gómez; José M Francos; Emilio Ramos; Antonio Rafecas; E Jaurrieta
Journal:  World J Surg       Date:  2006-11       Impact factor: 3.352

3.  Early recurrence of hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.

Authors:  K Sugino; T Mimura; O Ozaki; Y Kure; H Iwasaki; N Wada; A Matsumoto; K Ito
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

4.  Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease.

Authors:  T Okamoto; Y Fujimoto; T Obara; Y Ito; M Aiba
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

5.  Could total thyroidectomy become the standard treatment for Graves' disease?

Authors:  Ayhan Koyuncu; Cengiz Aydin; Omer Topçu; Oruç Numan Gökçe; Sahande Elagöz; Hatice Sebila Dökmetaş
Journal:  Surg Today       Date:  2009-12-29       Impact factor: 2.549

6.  Papillary thyroid carcinoma and inflammation.

Authors:  Laura Fugazzola; Carla Colombo; Michela Perrino; Marina Muzza
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-16       Impact factor: 5.555

7.  Changing trends in surgery for Graves' disease: a cohort comparison of those having surgery intended to preserve thyroid function with those having ablative surgery.

Authors:  Ahmed Al-Adhami; Ailsa C Snaith; Wendy L Craig; Zygmunt H Krukowski
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-05-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.